BROADCASTS.com

Episode #22 is another \u201cListener Q&A\u201d episode. Meb has been traveling again, this time giving several speeches. So we start the episode with Meb giving us the highlights from his most recent talk in Vegas, in which he details four mistakes that investors are making right now. Next, we get into our listener Q&A. Meb tackles:\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Is shareholder yield a smart beta factor in its own right, or is it a combination of factors?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Should a shareholder yield strategy outperform portfolios with size, value, and momentum tilts?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Is there a reason why Meb rarely talks about adding small caps to a portfolio?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0What are the merits of investing in ETFs versus bonds directly?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Can sentiment indicators be used to add tangible long-term value to a portfolio?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0How does Meb define risk, a term he uses quite often?\n-\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0While certain global countries with low CAPEs appear attractive, if the U.S. entered a correction, wouldn\u2019t those foreign countries follow, negating the decision to invest there?\nThere\u2019s plenty more, including talk of gambling in Vegas (and counting cards), Meb\u2019s high school reunion, and some of the worst investment losses Meb ever suffered (think \u201cbiotech\u201d and \u201coptions\u201d). Hear it all in Episode 22.\nLearn more about your ad choices. Visit megaphone.fm/adchoices